Avalo Therapeutics, Inc. (AVTX)
NASDAQ: AVTX · Real-Time Price · USD
13.42
-0.80 (-5.63%)
At close: Mar 20, 2026, 4:00 PM EDT
13.65
+0.23 (1.71%)
After-hours: Mar 20, 2026, 7:47 PM EDT
Avalo Therapeutics Market Cap
Avalo Therapeutics has a market cap or net worth of $243.36 million as of March 20, 2026. Its market cap has increased by 235.67% in one year.
Market Cap
243.36M
Enterprise Value
132.30M
1-Year Change
235.67%
Ranking
Category
Stock Price
$13.42
Market Cap Chart
Since November 13, 2015, Avalo Therapeutics's market cap has increased from $34.50M to $243.36M, an increase of 605.39%. That is a compound annual growth rate of 20.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 19, 2026 | 257.90M | -21.68% |
| Dec 31, 2025 | 329.30M | 326.55% |
| Dec 31, 2024 | 77.20M | 957.53% |
| Dec 29, 2023 | 7.30M | -84.60% |
| Dec 30, 2022 | 47.40M | -75.17% |
| Dec 31, 2021 | 190.90M | -3.49% |
| Dec 31, 2020 | 197.80M | -16.79% |
| Dec 31, 2019 | 237.70M | 80.35% |
| Dec 31, 2018 | 131.80M | 58.03% |
| Dec 29, 2017 | 83.40M | 917.07% |
| Dec 30, 2016 | 8.20M | -71.63% |
| Dec 31, 2015 | 28.90M | -16.23% |
| Nov 13, 2015 | 34.50M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Context Therapeutics | 274.72M |
| Orchestra BioMed Holdings | 271.54M |
| Camp4 Therapeutics | 267.90M |
| Polaryx Therapeutics | 267.49M |
| OmniAb | 266.40M |
| Abeona Therapeutics | 259.00M |
| Tenax Therapeutics | 256.42M |
| C4 Therapeutics | 254.68M |